HEALTH● LOWAug 20 · Aug 20, 2026, 6:30 PM
Experimental Drug Generates Immune Response Against Pancreatic Cancer in People at High Risk
GNN Science
Researchers at Johns Hopkins report that an experimental drug targeting one of the most common genetic drivers of pancreatic cancer was safe in humans, and generated durable immune responses aimed at preventing the cancer in people at high risk. Pancreatic cancer has one of the lowest survival rates of any form, and the developers believe […] The post Experimental Drug Generates Immune Response Against Pancreatic Cancer in People at High Risk appeared first on Good News Network.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH41m agoFrance reports first human case of Shamonda virus, but says there's no public health riskFrance 24 [en]HEALTH46m agoWhat to eat to have younger-looking skin?BBC AfriqueHEALTH48m agoLA HBCU Xavier University To Open Medical Schoolkfbk.iheart.com · United StatesHEALTH48m agoGetting health insurance from your job will be extra pricey for 2027kimt.com · United States